October, 2024
October 2024
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Vivek Subbiah: Huge win for patients with RET+ thyroid cancers.
Aug 25, 2023, 16:32

Vivek Subbiah: Huge win for patients with RET+ thyroid cancers.

Quoting Vivek Subbiah, the Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, on Twitter/X:

“Huge win for patients with RET+ thyroid cancers. Selpercatinib demonstrates Superior Progression-Free Survival Compared to Approved Multikinase Inhibitors in RET-Mutant Medullary Thyroid Cancer. Super thrilled and excited for all all RET+ patients globally. Knew that this baby would graduate with honors right from the 1st patient dosed.

Have you heard about Lazarus effect? Yes, this was the 1st ever RET+ Thyroid cancer patient dosed on the drug. Our clinic team witnessed 1st hand the power of precision medicine.

1. First RET+ patient story Annals of Oncology
sciencedirect.com/science/articl

2. NEJM paper
nejm.org/doi/pdf/10.105

3. Press release Loxo Oncology
investor.lilly.com/news-releases/

Source: Vivek Subbiah/Twitter